Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Learn more about Signatera and the foundational technology that is transforming care for patients with cancer. Hear directly from Natera CEO Steve Chapman on how Signatera can detect molecular residual disease and help determine whether therapy is working. #CancerCare #Signatera #MRD #Oncology #Natera

NateraGenetics's profile picture

Natera

13,938 subscribers

84,651 görüntüleme • 1 yıl önce •via X (Twitter)

Sağlık & İyilikBilim & TeknolojiEğitim#CancerCare
LIVE

Anya Rossi• Live Now

Private livecam show

1 Yorum

Randy Holcombe profil fotoğrafı
Randy Holcombe1 yıl önce

@SteveChapmanCEO In a case of post op colo-rectal cancer, what does it mean when CEA starts going up but Signatera is negative?

Benzer Videolar

Excited to share one of the new things I’m working on in oncology medtech… at LifeBridge Innovations, PBC we’re transforming Stage IV metastatic cancer from terminal to manageable! Please RT to help us bring hope to Stage IV patients! DM to learn more about how you can support our work.
2:49

Excited to share one of the new things I’m working on in oncology medtech… at LifeBridge Innovations, PBC we’re transforming Stage IV metastatic cancer from terminal to manageable! Please RT to help us bring hope to Stage IV patients! DM to learn more about how you can support our work.

Michael Hoyos

2,317,354 görüntüleme • 1 yıl önce

Our CEO, Steve Chapman, recently had the honor of ringing the opening bell on Nasdaq to celebrate our 10th anniversary as a public company. As part of the bell-ringing ceremony, Steve spoke about when and how Natera was founded — and how the company has evolved since then. We started with a dream to help people conceive healthy families and then applied what we knew about testing tiny quantities of DNA to preserve transplanted organs and detect cancer recurrence. Our work is grounded in science, anchored by constant innovation and applied by a talented team that is ushering in an entirely new area of disease management. Seeing Natera’s name in bright lights on the big screen in Times Square is an amazing nod to how far we’ve come and where we’re going. Congratulations to all Naterans!
2:03

Our CEO, Steve Chapman, recently had the honor of ringing the opening bell on Nasdaq to celebrate our 10th anniversary as a public company. As part of the bell-ringing ceremony, Steve spoke about when and how Natera was founded — and how the company has evolved since then. We started with a dream to help people conceive healthy families and then applied what we knew about testing tiny quantities of DNA to preserve transplanted organs and detect cancer recurrence. Our work is grounded in science, anchored by constant innovation and applied by a talented team that is ushering in an entirely new area of disease management. Seeing Natera’s name in bright lights on the big screen in Times Square is an amazing nod to how far we’ve come and where we’re going. Congratulations to all Naterans!

Natera

306,892 görüntüleme • 1 yıl önce

In case you missed it 👀 From patient to minister - hear about Ashley Dalton MP's cancer journey and how she's leading the National Cancer Plan. Working with patients and charities, we're focused on quicker diagnosis, latest treatments and helping people live well with cancer.
1:06

In case you missed it 👀 From patient to minister - hear about Ashley Dalton MP's cancer journey and how she's leading the National Cancer Plan. Working with patients and charities, we're focused on quicker diagnosis, latest treatments and helping people live well with cancer.

Department of Health and Social Care

20,655 görüntüleme • 7 ay önce

"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you." On #WorldCancerDay, our 2018 medicine laureates reflect on the hope their remarkable cancer therapy gives to patients around the globe.
1:21

"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you." On #WorldCancerDay, our 2018 medicine laureates reflect on the hope their remarkable cancer therapy gives to patients around the globe.

The Nobel Prize

101,885 görüntüleme • 3 yıl önce

“If I didn’t have this test, I would have no idea I have stage four cancer.” Over the weekend I attended the Young Survival Coalition conference where I met Lori. Lori was diagnosed with stage two breast cancer in 2024 and completed treatment. When she asked what monitoring would look like afterward, she was told it would mostly be based on symptoms. That wasn’t good enough for her. She asked for the Signatera test to detect recurrence earlier. Her oncologist supported it…but insurance denied it multiple times. And here’s the part that stopped me in my tracks: the test was ordered by her oncologist, but the denial was signed by a family medicine doctor working for the insurance company. Lori told me something during our conversation that meant a lot to me: watching my videos helped her understand how important patient advocacy is, and it gave her the determination to keep pushing. Eventually she was able to get the test. Her first result was negative. Four months later, the second test came back positive. A PET scan confirmed stage four metastatic breast cancer with no symptoms. Because she advocated for herself, her cancer was detected earlier than it otherwise would have been. That means more treatment options and a different path forward. Lori, it was an honor to meet you. Your courage and determination are going to help so many other patients learn to advocate for themselves too. Natera HHS
1:50

“If I didn’t have this test, I would have no idea I have stage four cancer.” Over the weekend I attended the Young Survival Coalition conference where I met Lori. Lori was diagnosed with stage two breast cancer in 2024 and completed treatment. When she asked what monitoring would look like afterward, she was told it would mostly be based on symptoms. That wasn’t good enough for her. She asked for the Signatera test to detect recurrence earlier. Her oncologist supported it…but insurance denied it multiple times. And here’s the part that stopped me in my tracks: the test was ordered by her oncologist, but the denial was signed by a family medicine doctor working for the insurance company. Lori told me something during our conversation that meant a lot to me: watching my videos helped her understand how important patient advocacy is, and it gave her the determination to keep pushing. Eventually she was able to get the test. Her first result was negative. Four months later, the second test came back positive. A PET scan confirmed stage four metastatic breast cancer with no symptoms. Because she advocated for herself, her cancer was detected earlier than it otherwise would have been. That means more treatment options and a different path forward. Lori, it was an honor to meet you. Your courage and determination are going to help so many other patients learn to advocate for themselves too. Natera HHS

Elisabeth Potter MD

32,826 görüntüleme • 6 ay önce

At the Coalition for Metabolic Health, we're working to address America's chronic disease crisis. Learn more about our mission to make metabolic health mainstream—and hear directly from some of our experts—in our new video:
7:20

At the Coalition for Metabolic Health, we're working to address America's chronic disease crisis. Learn more about our mission to make metabolic health mainstream—and hear directly from some of our experts—in our new video:

Coalition for Metabolic Health

17,210 görüntüleme • 6 ay önce

At Oklo, our isotope work is personal. Some members of our team have spent decades advancing the technology that shows up in critical moments, from disease diagnosis and cancer care to space exploration. That dedication shows up in how Oklo is built, and shapes how we think about deployment, bringing power, fuel, and isotopes together into a single platform designed to deliver more from nuclear technology. Watch here:
4:48

At Oklo, our isotope work is personal. Some members of our team have spent decades advancing the technology that shows up in critical moments, from disease diagnosis and cancer care to space exploration. That dedication shows up in how Oklo is built, and shapes how we think about deployment, bringing power, fuel, and isotopes together into a single platform designed to deliver more from nuclear technology. Watch here:

Oklo

21,743 görüntüleme • 3 ay önce

"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you." On World Cancer Day, medicine laureates James Allison and Tasuku Honjo share their personal experiences with cancer and the hope their remarkable cancer treatment - immunotherapy - gives to patients around the globe. #WorldCancerDay
1:21

"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you." On World Cancer Day, medicine laureates James Allison and Tasuku Honjo share their personal experiences with cancer and the hope their remarkable cancer treatment - immunotherapy - gives to patients around the globe. #WorldCancerDay

The Nobel Prize

16,921 görüntüleme • 1 yıl önce

Is 5G only beneficial for phones and devices? Actually, no! #5G is also transforming industries. So, how can this technology make warehouses more efficient and sustainable? Watch to find out and learn how #Huawei is changing the game in Indonesia! #InnovateForImpact
6:14

Is 5G only beneficial for phones and devices? Actually, no! #5G is also transforming industries. So, how can this technology make warehouses more efficient and sustainable? Watch to find out and learn how #Huawei is changing the game in Indonesia! #InnovateForImpact

Huawei

34,448,846 görüntüleme • 2 yıl önce

The Liberty Basketball family is praying for former Flame Jesse Sanders as he battles cancer. To learn more about his battle and how you can help, please visit this link:
4:06

The Liberty Basketball family is praying for former Flame Jesse Sanders as he battles cancer. To learn more about his battle and how you can help, please visit this link:

Liberty Men's Basketball

10,764 görüntüleme • 1 yıl önce

"Quick update from Lori, Andrew is doing so well with continued clean scans and strength after ANKTIVA + NK cell therapy. Plus the latest on our FDA advocacy, the new documentary, and how we’re pushing to make these treatments available to more cancer patients nationwide. Cancer is losing this fight! Bullish
2:05

"Quick update from Lori, Andrew is doing so well with continued clean scans and strength after ANKTIVA + NK cell therapy. Plus the latest on our FDA advocacy, the new documentary, and how we’re pushing to make these treatments available to more cancer patients nationwide. Cancer is losing this fight! Bullish

Lori Mills

19,414 görüntüleme • 2 ay önce

"This isn't just a cancer therapy, this is a way of liberating people from the burden of having this disease that can come back and kill you." James Allison and Tasuku Honjo were awarded the 2018 medicine prize. Read more about their discovery:
1:21

"This isn't just a cancer therapy, this is a way of liberating people from the burden of having this disease that can come back and kill you." James Allison and Tasuku Honjo were awarded the 2018 medicine prize. Read more about their discovery:

The Nobel Prize

47,153 görüntüleme • 1 ay önce

"This isn't just a cancer therapy, this is a way of liberating people from the burden of having this disease that can come back and kill you." James Allison and Tasuku Honjo were awarded the 2018 medicine prize. Read more about their discovery:
1:21

"This isn't just a cancer therapy, this is a way of liberating people from the burden of having this disease that can come back and kill you." James Allison and Tasuku Honjo were awarded the 2018 medicine prize. Read more about their discovery:

The Nobel Prize

18,020 görüntüleme • 1 yıl önce

Dr. David Izquierdo and his team developed the novel radiotracer [64Cu]-FBP8 that can identify fibrin accumulation in the lung, brain and heart tissue of Long COVID patients when visualized with PET. “Now the question is; can we [use this technology] with patients that have symptoms, but don’t have any clinical evidence,” said Izquierdo. “What we’re trying to do here is determine if Long COVID has a signal that we can measure, quantify and detect in vivo, noninvasively.”
5:08

Dr. David Izquierdo and his team developed the novel radiotracer [64Cu]-FBP8 that can identify fibrin accumulation in the lung, brain and heart tissue of Long COVID patients when visualized with PET. “Now the question is; can we [use this technology] with patients that have symptoms, but don’t have any clinical evidence,” said Izquierdo. “What we’re trying to do here is determine if Long COVID has a signal that we can measure, quantify and detect in vivo, noninvasively.”

PolyBio

27,657 görüntüleme • 5 ay önce

We are excited to be working on a new research study which is aiming to create a lateral flow test (LFT) to determine whether a patient is suffering a stroke. We are working alongside the University of Birmingham and University Hospitals Birmingham on the Ghost study, which will see us obtain saliva from patients who are demonstrating stroke symptoms, to help create an LFT which in turn will help to speed up access to brain-saving treatment and saving more patients. You can read more here -
1:51

We are excited to be working on a new research study which is aiming to create a lateral flow test (LFT) to determine whether a patient is suffering a stroke. We are working alongside the University of Birmingham and University Hospitals Birmingham on the Ghost study, which will see us obtain saliva from patients who are demonstrating stroke symptoms, to help create an LFT which in turn will help to speed up access to brain-saving treatment and saving more patients. You can read more here -

West Midlands Ambulance Service #HelpUsHelpYou

20,530 görüntüleme • 1 yıl önce

Plus Therapeutics $PSTV is a biotechnology company focused on developing innovative, targeted treatments and cutting-edge diagnostics for adults and children with difficult-to-treat cancer. They are advancing key programs, including the diagnostic platform CNSide and the targeted radiotherapeutic REYOBIQ™. Katie Perry sat down with President & CEO Dr. Marc Hedrick to discuss how Plus Therapeutics (Nasdaq: PSTV) is utilizing technology to deliver personalized and effective treatment strategies for oncology patients by providing actionable insights.
12:19

Plus Therapeutics $PSTV is a biotechnology company focused on developing innovative, targeted treatments and cutting-edge diagnostics for adults and children with difficult-to-treat cancer. They are advancing key programs, including the diagnostic platform CNSide and the targeted radiotherapeutic REYOBIQ™. Katie Perry sat down with President & CEO Dr. Marc Hedrick to discuss how Plus Therapeutics (Nasdaq: PSTV) is utilizing technology to deliver personalized and effective treatment strategies for oncology patients by providing actionable insights.

Stocktwits

13,355 görüntüleme • 9 ay önce

Curious about what $SOIL is and how tokenization is transforming the markets? Let’s hear it straight from our founders. 🎥 Join our CEO, CIO, and CMO as they break down #RWA tokenization concept—and what it means for SOIL 👇
1:00

Curious about what $SOIL is and how tokenization is transforming the markets? Let’s hear it straight from our founders. 🎥 Join our CEO, CIO, and CMO as they break down #RWA tokenization concept—and what it means for SOIL 👇

Soil

119,811 görüntüleme • 1 yıl önce